• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿根廷跨性别女性对艾滋病毒暴露前预防用药的高使用意愿

High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina.

作者信息

Zalazar Virginia, Arístegui Inés, Kerr Thomas, Marshall Brandon D L, Romero Marcela, Sued Omar, Socías M Eugenia

机构信息

Fundación Huésped, Buenos Aires, Argentina.

Universidad de Palermo, Buenos Aires, Argentina.

出版信息

Transgend Health. 2016 Dec 1;1(1):266-273. doi: 10.1089/trgh.2016.0033. eCollection 2016.

DOI:10.1089/trgh.2016.0033
PMID:28861540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5367484/
Abstract

In Argentina, transgender women face a disproportionately high prevalence of HIV infection (34%). Although not currently approved in Argentina, pre-exposure prophylaxis (PrEP) may offer a potential effective HIV prevention tool for this population. In this study, we assessed the willingness to use PrEP among transgender women in Argentina. Data were drawn from a nationwide cross-sectional survey conducted among transgender women in 2013. Using multivariable logistic regression, we assessed the prevalence of and factors associated with willingness to use PrEP among transgender women with negative or unknown HIV status. This study included 337 transgender women (278 HIV negative and 59 with unknown HIV status), most of whom had a history of sex work involvement (81.8%). Overall, 301 (89.3%) expressed willingness to use PrEP. In a multivariable analysis, having casual sexual partners was positively associated with willingness to use PrEP (adjusted odds ratio [AOR]=4.26, 95% confidence interval [CI] 1.73-10.51), while discrimination by healthcare workers was negatively associated (AOR=0.33, 95% CI 0.12-0.88). We found high levels of willingness to use PrEP among transgender women in Argentina, suggesting that there is high perception of HIV risk in this population. However, discrimination by healthcare workers was a strong negative correlate of willingness to use PrEP, suggesting that multilevel interventions that address gender-based stigma in healthcare settings will be critical for the success of PrEP as an HIV prevention strategy in this population.

摘要

在阿根廷,跨性别女性感染艾滋病毒的比例极高(34%)。虽然暴露前预防(PrEP)目前在阿根廷尚未获批,但它可能为这一人群提供一种潜在有效的艾滋病毒预防工具。在本研究中,我们评估了阿根廷跨性别女性使用PrEP的意愿。数据来自2013年对跨性别女性进行的一项全国性横断面调查。我们使用多变量逻辑回归,评估了艾滋病毒检测呈阴性或状况不明的跨性别女性中使用PrEP意愿的患病率及相关因素。本研究纳入了337名跨性别女性(278名艾滋病毒检测呈阴性,59名状况不明),其中大多数有性工作经历(81.8%)。总体而言,301名(89.3%)表示愿意使用PrEP。在多变量分析中,有临时性伴侣与使用PrEP的意愿呈正相关(调整后的优势比[AOR]=4.26,95%置信区间[CI]为1.73 - 10.51),而医护人员的歧视则呈负相关(AOR=0.33,95%CI为0.12 - 0.88)。我们发现阿根廷的跨性别女性对使用PrEP的意愿很高,这表明该人群对艾滋病毒风险的认知度很高。然而,医护人员的歧视是使用PrEP意愿的一个强烈负相关因素,这表明解决医疗环境中基于性别的污名化问题的多层次干预措施对于PrEP作为该人群艾滋病毒预防策略的成功实施至关重要。

相似文献

1
High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina.阿根廷跨性别女性对艾滋病毒暴露前预防用药的高使用意愿
Transgend Health. 2016 Dec 1;1(1):266-273. doi: 10.1089/trgh.2016.0033. eCollection 2016.
2
Low awareness but high acceptability of pre-exposure prophylaxis for HIV among men who have sex with men and transgender persons in Delhi, India.印度德里男男性行为者和跨性别者对 HIV 暴露前预防措施的认识度低,但接受度高。
Int J STD AIDS. 2023 Oct;34(11):763-776. doi: 10.1177/09564624231174936. Epub 2023 Jun 3.
3
Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.中国跨性别女性对使用艾滋病毒暴露前预防(PrEP)的认知和意愿:一项社区为基础的调查。
AIDS Behav. 2021 Mar;25(3):866-874. doi: 10.1007/s10461-020-03050-6. Epub 2020 Sep 28.
4
PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.南非跨性别女性对 PrEP 的认知和参与情况:一项横断面混合方法研究。
Lancet HIV. 2020 Dec;7(12):e825-e834. doi: 10.1016/S2352-3018(20)30119-3. Epub 2020 Jul 2.
5
Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.巴西、墨西哥和秘鲁跨性别女性中与长期 HIV 暴露前预防参与和坚持相关的因素:ImPrEP 研究结果。
J Int AIDS Soc. 2022 Oct;25 Suppl 5(Suppl 5):e25974. doi: 10.1002/jia2.25974.
6
Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India.印度变性女性中影响使用人类免疫缺陷病毒暴露前预防意愿的因素
Transgend Health. 2021 Apr 16;6(2):64-73. doi: 10.1089/trgh.2019.0076. eCollection 2021 Apr.
7
A Gap Between Willingness and Uptake: Findings From Mixed Methods Research on HIV Prevention Among Black and Latina Transgender Women.意愿与接受度之间的差距:混合方法研究在黑人和拉丁裔跨性别女性中的 HIV 预防发现。
J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):131-140. doi: 10.1097/QAI.0000000000002112.
8
Willingness to use pre-exposure prophylaxis for HIV prevention among female sex workers: a cross-sectional study in China.女性性工作者中使用暴露前预防措施预防艾滋病的意愿:一项中国的横断面研究。
HIV AIDS (Auckl). 2012;4:149-58. doi: 10.2147/HIV.S33445. Epub 2012 Sep 24.
9
Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.中国大陆 HIV 阴性/未知的男男性行为者使用长效注射型 PrEP 的意愿:一项横断面在线调查。
PLoS One. 2023 Oct 19;18(10):e0293297. doi: 10.1371/journal.pone.0293297. eCollection 2023.
10
Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia.马来西亚跨性别女性中使用暴露前预防(PrEP)预防艾滋病毒的意愿及PrEP实施偏好
Transgend Health. 2020 Dec 11;5(4):258-266. doi: 10.1089/trgh.2020.0003. eCollection 2020 Dec.

引用本文的文献

1
A scoping review examining measurement of anti-transgender stigma in low- and middle-income countries.一项审视低收入和中等收入国家中反跨性别者污名化衡量指标的范围综述。
PLOS Glob Public Health. 2025 Apr 30;5(4):e0004490. doi: 10.1371/journal.pgph.0004490. eCollection 2025.
2
Experiences of violence and abuse among transgender women in healthcare settings in Uganda: a community-engaged qualitative study.乌干达医疗环境中跨性别女性的暴力和虐待经历:一项社区参与的定性研究。
BMC Health Serv Res. 2025 Mar 26;25(1):431. doi: 10.1186/s12913-025-12591-2.
3
Factors Associated with Planned Future Use of PrEP in the Next 3 Months and Likelihood to Use PrEP Among Black Cisgender HIV-negative Women in Texas.德克萨斯州黑人跨性别 HIV 阴性女性未来 3 个月计划使用 PrEP 的相关因素及其使用 PrEP 的可能性。
AIDS Behav. 2024 Jan;28(1):72-92. doi: 10.1007/s10461-023-04188-9. Epub 2023 Sep 28.
4
HIV Risk Perception and Pre-Exposure Prophylaxis (PrEP) Awareness Among Transgender Women from Mexico.墨西哥跨性别女性的艾滋病毒风险认知和暴露前预防(PrEP)知晓情况
AIDS Behav. 2023 Mar;27(3):992-1002. doi: 10.1007/s10461-022-03836-w. Epub 2022 Sep 19.
5
Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India.印度变性女性中影响使用人类免疫缺陷病毒暴露前预防意愿的因素
Transgend Health. 2021 Apr 16;6(2):64-73. doi: 10.1089/trgh.2019.0076. eCollection 2021 Apr.
6
Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia.马来西亚跨性别女性中使用暴露前预防(PrEP)预防艾滋病毒的意愿及PrEP实施偏好
Transgend Health. 2020 Dec 11;5(4):258-266. doi: 10.1089/trgh.2020.0003. eCollection 2020 Dec.
7
Pre and Post-exposure Prophylaxis Awareness and Acceptability Among Sex Workers in Jamaica: A Cross-Sectional Study.在牙买加,性工作者对暴露前和暴露后预防措施的认知和接受度:一项横断面研究。
AIDS Behav. 2021 Feb;25(2):330-343. doi: 10.1007/s10461-020-02972-5.
8
Use of HIV Self-Testing Kits to Screen Clients Among Transgender Female Sex Workers in New York and Puerto Rico.在纽约和波多黎各的跨性别女性性工作者中使用 HIV 自我检测试剂盒进行筛查。
AIDS Behav. 2020 Feb;24(2):506-515. doi: 10.1007/s10461-019-02730-2.
9
Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men.与顺性别男性相比,同时服用雌激素的跨性别女性服用口服 HIV 暴露前预防药物时,替诺福韦和恩曲他滨的浓度明显较低。
J Int AIDS Soc. 2019 Nov;22(11):e25405. doi: 10.1002/jia2.25405.
10
The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention.拉丁美洲的艾滋病疫情:治疗和预防方面的成就与挑战。
Curr Opin HIV AIDS. 2019 Sep;14(5):366-373. doi: 10.1097/COH.0000000000000564.

本文引用的文献

1
'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.“我不是男人”:跨性别女性中暴露前预防(PrEP)可接受性的跨性别特定障碍与促进因素
Glob Public Health. 2016 Aug-Sep;11(7-8):1060-75. doi: 10.1080/17441692.2016.1154085. Epub 2016 Mar 10.
2
Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US.性传播感染与暴露前预防:美国男男性行为者面临的挑战与机遇
AIDS Res Ther. 2016 Jan 19;13:5. doi: 10.1186/s12981-016-0089-8. eCollection 2016.
3
Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.预防艾滋病病毒暴露前预防革命中关于坚持暴露前预防的当前概念:从临床试验到常规实践。
Curr Opin HIV AIDS. 2016 Jan;11(1):10-7. doi: 10.1097/COH.0000000000000220.
4
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.按需暴露前预防治疗在 HIV-1 感染高危男性中的应用。
N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.
5
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.HIV 暴露前预防在跨性别女性中的应用:iPrEx 试验的亚组分析。
Lancet HIV. 2015 Dec;2(12):e512-9. doi: 10.1016/S2352-3018(15)00206-4. Epub 2015 Nov 6.
6
Prevalence and Correlates of Lifetime Suicide Attempts Among Transgender Persons in Argentina.阿根廷跨性别者终身自杀未遂的患病率及其相关因素
J Homosex. 2016 Jul;63(7):955-67. doi: 10.1080/00918369.2015.1117898. Epub 2015 Nov 13.
7
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.暴露前预防以预防HIV-1感染(PROUD):一项实用开放标签随机试验试点阶段的有效性结果
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
8
Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women.多地点未感染艾滋病毒的年轻跨性别女性队列中暴露前预防指征的相关因素
AIDS Behav. 2016 Jul;20(7):1470-7. doi: 10.1007/s10461-015-1182-z.
9
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".围绕艾滋病毒暴露前预防用药的污名如何破坏预防和愉悦:呼吁消除对“特鲁瓦达妓女”的污名化
Am J Public Health. 2015 Oct;105(10):1960-4. doi: 10.2105/AJPH.2015.302816. Epub 2015 Aug 13.
10
Inclusion of trans women in pre-exposure prophylaxis trials: a review.将跨性别女性纳入暴露前预防试验:一项综述。
AIDS Care. 2015;27(5):637-41. doi: 10.1080/09540121.2014.986051. Epub 2014 Nov 28.